Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4151
Gene Symbol: MB
MB
0.010 Biomarker disease BEFREE Compared with HF-HD, MCO-HD provides higher myoglobin and other middle molecules RR and is associated with moderate hypoalbuminemia. 31578564 2020
Entrez Id: 5319
Gene Symbol: PLA2G1B
PLA2G1B
0.010 Biomarker disease BEFREE Of the 21 individuals with documented prediagnostic NNRP, 43% (nine out of 21) were seropositive before NNRP was first documented and 28.5% (six out of 21) were seropositive at the same time as NNRP; 66% (39 out of 59) of those seropositive for PLA2R-AB had hypoalbuminemia present at the time antibody was initially detected. 31843984 2020
Entrez Id: 151056
Gene Symbol: PLB1
PLB1
0.010 Biomarker disease BEFREE Of the 21 individuals with documented prediagnostic NNRP, 43% (nine out of 21) were seropositive before NNRP was first documented and 28.5% (six out of 21) were seropositive at the same time as NNRP; 66% (39 out of 59) of those seropositive for PLA2R-AB had hypoalbuminemia present at the time antibody was initially detected. 31843984 2020
Entrez Id: 7534
Gene Symbol: YWHAZ
YWHAZ
0.010 Biomarker disease BEFREE Of the 21 individuals with documented prediagnostic NNRP, 43% (nine out of 21) were seropositive before NNRP was first documented and 28.5% (six out of 21) were seropositive at the same time as NNRP; 66% (39 out of 59) of those seropositive for PLA2R-AB had hypoalbuminemia present at the time antibody was initially detected. 31843984 2020
Entrez Id: 3586
Gene Symbol: IL10
IL10
0.010 AlteredExpression disease BEFREE Compared with HIV-associated diffuse large B-cell lymphoma, PEL was associated with significant hypoalbuminemia (<i>P</i> < .0027), thrombocytopenia (<i>P</i> = .0045), and elevated IL-10 levels (<i>P</i> < .0001). 30782610 2019
Entrez Id: 1437
Gene Symbol: CSF2
CSF2
0.010 Biomarker disease BEFREE Linear growth impairment was associated with hypoalbuminemia (P = 0.0052), elevated granulocyte-macrophage colony stimulating factor autoantibodies (P = 0.0110), and elevated CBir antibodies against flagellin (P = 0.0117). 31393333 2019
Entrez Id: 3558
Gene Symbol: IL2
IL2
0.010 AlteredExpression disease BEFREE Characteristic features included persistent fever (41/42, 97·6%), decreased performance status (≥2) (100%), hypoxaemia (32/40, 80·0%), impaired consciousness (19/42, 45·2%), hypoalbuminemia (42/42, 100%) and extreme elevation of lactate dehydrogenase and soluble interleukin 2 receptor levels. 31267524 2019
Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1
0.010 Biomarker disease BEFREE The liver <sup>18</sup>F-FDG uptake tended to decrease in patients with hypoalbuminemia. 31201673 2019
Entrez Id: 4582
Gene Symbol: MUC1
MUC1
0.010 Biomarker disease BEFREE We assessed the impact of indicators of protein-energy malnutrition [PEM] including hypoalbuminaemia, weight loss, and body mass index on postoperative outcomes. 31253985 2019
Entrez Id: 130074
Gene Symbol: FAM168B
FAM168B
0.010 Biomarker disease BEFREE In the 14 patients with severe kidney dysfunction and hypoalbuminemia, none of the coefficients had a P20 accuracy greater than 45%. 31067355 2019
Entrez Id: 8074
Gene Symbol: FGF23
FGF23
0.010 Biomarker disease BEFREE Hypoalbuminemia significantly increased the fibroblast growth factor-23 (FGF-23) and procollagen type 1N-terminal propeptide (P1NP) in PTH ≤150 pg/mL, PTH 150-300 pg/mL, PTH 300-600 pg/mL groups, whereas no such relation was noted among PTH> 600 ng/dL group. 31839746 2019
Entrez Id: 107986209
Gene Symbol: H3P14
H3P14
0.010 Biomarker disease BEFREE In the 14 patients with severe kidney dysfunction and hypoalbuminemia, none of the coefficients had a P20 accuracy greater than 45%. 31067355 2019
Entrez Id: 51673
Gene Symbol: TPPP3
TPPP3
0.010 Biomarker disease BEFREE In the 14 patients with severe kidney dysfunction and hypoalbuminemia, none of the coefficients had a P20 accuracy greater than 45%. 31067355 2019
Entrez Id: 54535
Gene Symbol: CCHCR1
CCHCR1
0.010 AlteredExpression disease BEFREE Controlling volume variation, avoiding hypoalbuminemia and reducing blood calcium levels might reduce SBP variability and thereby improve prognoses in these patients. 29421796 2018
Entrez Id: 6462
Gene Symbol: SHBG
SHBG
0.010 AlteredExpression disease BEFREE Controlling volume variation, avoiding hypoalbuminemia and reducing blood calcium levels might reduce SBP variability and thereby improve prognoses in these patients. 29421796 2018
Entrez Id: 8991
Gene Symbol: SELENBP1
SELENBP1
0.010 AlteredExpression disease BEFREE Controlling volume variation, avoiding hypoalbuminemia and reducing blood calcium levels might reduce SBP variability and thereby improve prognoses in these patients. 29421796 2018
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.010 Biomarker disease BEFREE Comorbidities included the following: obesity (n = 95, 78.5%), hypertension (n = 72, 59.5%), cardiovascular disease (n = 42, 34.7%), diabetes (n = 40, 33.1%), COPD (n = 34, 28.1%), malignancy (n = 30, 24.8%), active smoker (n = 28, 23.1%), immunosuppression (n = 10, 8.3%), chronic corticosteroid use (n = 6, 5.0%), advanced age (n = 6, 5.0%), hypoalbuminemia (n = 3, 2.5%), and renal insufficiency (n = 1, 0.8%). 29063307 2018
Entrez Id: 3645
Gene Symbol: INSRR
INSRR
0.010 GeneticVariation disease BEFREE Significant risk factors of peritonitis were severe obesity (incidence-rate ratio [IRR] 3.32, 95% confidence interval [CI]: 1.30, 8.45), hypoalbuminemia (IRR 1.61, 95% CI: 1.06, 2.46), Staphylococcus aureus nasal carriage (IRR 2.26, 95% CI: 1.46, 3.50), and use of Fresenius system (Fresenius Medical Care North America, Waltham, MA, USA) (IRR 2.49, 95% CI: 1.27, 4.89). 27147287 2017
Entrez Id: 26503
Gene Symbol: SLC17A5
SLC17A5
0.010 Biomarker disease BEFREE Abnormal laboratory test results included: elevated total/ conjugated (direct) bilirubin, AST, ALT, PT, APTT, creatinine, leukocyte count, and hypoalbuminemia. 29034746 2017
Entrez Id: 23659
Gene Symbol: PLA2G15
PLA2G15
0.010 Biomarker disease BEFREE The purpose of our study is to determine if there is an association between preoperative hypoalbuminemia and 30-day patient morbidity and mortality in colon cancer patients using the Targeted-Colectomy American College of Surgeons National Surgery Quality Improvement Program (ACS-NSQIP). 27612919 2017
Entrez Id: 84680
Gene Symbol: ACCS
ACCS
0.010 Biomarker disease BEFREE The purpose of our study is to determine if there is an association between preoperative hypoalbuminemia and 30-day patient morbidity and mortality in colon cancer patients using the Targeted-Colectomy American College of Surgeons National Surgery Quality Improvement Program (ACS-NSQIP). 27612919 2017
Entrez Id: 55902
Gene Symbol: ACSS2
ACSS2
0.010 Biomarker disease BEFREE The purpose of our study is to determine if there is an association between preoperative hypoalbuminemia and 30-day patient morbidity and mortality in colon cancer patients using the Targeted-Colectomy American College of Surgeons National Surgery Quality Improvement Program (ACS-NSQIP). 27612919 2017
Entrez Id: 2091
Gene Symbol: FBL
FBL
0.010 Biomarker disease BEFREE The observed hypoalbuminemia and increase of FIB concentrations referred to pro-inflammatory cytokines production. 28571746 2017
Entrez Id: 796
Gene Symbol: CALCA
CALCA
0.010 Biomarker disease BEFREE Release of calcitonin and hypoalbuminemia are two proposed reasons. 27715340 2017
Entrez Id: 1312
Gene Symbol: COMT
COMT
0.010 GeneticVariation disease BEFREE Besides several known risk factors such as hypomagnesemia and hypoalbuminemia, the patient also proved to be homozygously polymorphic for two polymorphisms within the COMT gene (c.615 + 310C>T and c.616-367C>T). 28560854 2017